Trials / Completed
CompletedNCT04858022
Visual Acoustic Biofeedback for RSE Via Telepractice
Online Assessment and Enhancement of Auditory Perception for Speech Sound Errors: Visual Acoustic Biofeedback for RSE Via Telepractice
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Montclair State University · Academic / Other
- Sex
- All
- Age
- 9 Years – 15 Years
- Healthy volunteers
- Accepted
Summary
This research will meet a public health need by evaluating the efficacy of speech intervention supplemented with real-time visual-acoustic biofeedback when delivered using remote technologies.
Detailed description
In a crossover design, participants will be randomly assigned to receive 10 weeks/20 sessions of visual-acoustic biofeedback treatment via telepractice followed by a 10-week period of no treatment, or the same two conditions in the reverse order. Production accuracy will be assessed with standard probes (20 syllables, 30 words, and 10 sentences containing /r/ in various phonetic contexts) administered prior to the beginning of treatment (baseline), after the first 10-week phase, and again at the end of the study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Visual-Acoustic Biofeedback Treatment | In visual-acoustic biofeedback treatment, the elements of traditional articulatory treatment (i.e., auditory models and verbal descriptions of articulator placement) are enhanced with a dynamic display of the speech signal in the form of the real-time LPC (Linear Predictive Coding) spectrum. Because correct vs incorrect productions of /r/ contrast acoustically in the frequency of the third formant (F3), participants will be cued to make their real-time LPC spectrum match a visual target characterized by a low F3 frequency. They will be encouraged to attend to the visual display while adjusting the placement of their articulators and observing how those adjustments impact F3. |
| OTHER | No Treatment | 10-week period of no treatment |
Timeline
- Start date
- 2022-01-15
- Primary completion
- 2024-04-15
- Completion
- 2024-04-15
- First posted
- 2021-04-23
- Last updated
- 2026-02-17
- Results posted
- 2026-02-17
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04858022. Inclusion in this directory is not an endorsement.